Synthes
| Synthes, Inc.
|
|
|---|---|
 |
|
| legal form | Incorporated |
| founding | 1954 |
| Seat | West Chester , Pennsylvania , United States |
| management | Michel Orsinger ( President and CEO ) |
| Number of employees | 11,426 (December 31, 2010) |
| sales | 3,687,000,000 US dollars (2010) |
| Branch | Medical technology |
| Website | www.synthes.com |
Synthes is a US medical technology company with Swiss roots and is a subsidiary of Johnson & Johnson . There it is part of the DePuy Synthes Companies division. The company develops, produces and markets instruments, implants and biomaterials for the surgical treatment of bone fractures and for the correction and reconstruction of the human skeleton and its soft tissues.
Synthes employs around 10,000 people worldwide and had 2009 sales of $ 3.394 billion. The company had been listed on the SIX Swiss Exchange since 1996 and was included in the Swiss Market Index . The main shareholder with a stake of 40 percent was the Chairman of the Board of Directors and long-standing CEO, Hansjörg Wyss .
history
The company has its roots in the Straumann Institute , founded in 1954 by Reinhard Straumann in Waldenburg , from which the Straumann Group emerged. The Straumann Institute specialized in the development of new metal alloys, the testing of material properties and the research into practical applications. In 1974 Straumann's North America business was spun off under the name Synthes USA, and from 1977 onwards it was managed by Hansjörg Wyss .
In 1990 the Osteosynthesis division was spun off from what was then Institut Straumann AG under the name Stratec and based in Oberdorf through a management buy-out . In 1996 Stratec went public. In 1999 Stratec was merged with Synthes USA, which had also emerged from the Straumann Institute, to form Synthes-Stratec, Inc. In 2003, the takeover of Spine Solutions, which specializes in the development of artificial intervertebral discs, followed. In 2004 Synthes-Stratec took over the osteosynthesis division of Mathys Medizinaltechnik AG, founded in 1946, and became Synthes, Inc.
In 2011/2012 Synthes was sold to the American pharmaceutical and consumer goods manufacturer Johnson & Johnson for 19.7 billion US dollars and was transferred together with Depuy to the new DePuy Synthes division . The headquarters of the European business in particular has been Zuchwil in Solothurn since 2012 .
Web links
- Company website
- Annual report 2008 (PDF file; 1.93 MB)
Individual evidence
- ↑ a b Portrait of Synthes. (pdf) Archived from the original on November 24, 2006 ; Retrieved February 2, 2013 .
- ↑ a b http://www.clinpage.com/images/uploads/Synthes-2011.pdf
- ^ Synthes, Corporate Governance. Retrieved July 12, 2009 .
- ↑ Unknown billionaire. NZZ on Sunday , May 7, 2006, accessed on March 29, 2019 .
- ^ Johnson & Johnson Announces Completion of Synthes Acquisition. (No longer available online.) June 14, 2012, archived from the original on February 4, 2013 ; accessed on February 2, 2013 . Info: The archive link was inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice.
- ↑ Synthes remains loyal to Switzerland. Neue Zürcher Zeitung , June 13, 2012, accessed on February 2, 2013 .
- ↑ Synthes Switzerland website
- ↑ Date of relocation ( Memento of the original from February 17, 2015 in the Internet Archive ) Info: The archive link was inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice.
